Search company, investor...
BioAgilytix Labs company logo

BioAgilytix Labs

Founded Year



Acq - Fin - II | Alive

Total Raised


About BioAgilytix Labs

BioAgilytix Labs is a specialized bioanalytical testing laboratory focused on large molecule bioanalysis for the pharmaceutical, biotechnology and agriculture industries. BioAgilytix Labs aims to provide outsourced analysis of biological samples that supports the work of companies seeking regulatory approval of their biopharmaceutical and agricultural products.

Headquarters Location

2300 Englert Drive

Durham, North Carolina, 27713,

United States


Missing: BioAgilytix Labs's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BioAgilytix Labs's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

BioAgilytix Labs Patents

BioAgilytix Labs has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • Complement system
  • Immune system
patents chart

Application Date

Grant Date


Related Topics



Immunology, Monoclonal antibodies, Complement system, Immune system, Biotechnology


Application Date


Grant Date


Related Topics

Immunology, Monoclonal antibodies, Complement system, Immune system, Biotechnology



Latest BioAgilytix Labs News

BioAgilytix Appoints Dr. Linda Robbie as COO

Aug 19, 2022

Robbie has more than 25 years of experience with biomarker assay technologies, including 20 years of experience in scientific leadership positions. 08.18.22 BioAgilytix Labs LLC , a contract research organization supporting pharmaceutical and biotech partners in all phases of drug development, has appointed Dr. Linda Robbie as chief operating officer, effective August 9, 2022. For the past three years, Robbie has served as vice president and general manager of Boston operations, responsible for leading all Bioanalytical Services at BioAgilytix’s Boston, MA Laboratory. During this time, she directed all initiatives relating to science, technology, and laboratory operations. Robbie has more than 25 years of experience with biomarker assay technologies, including 20 years of experience in scientific leadership positions. She was previously senior vice president of Science and Laboratory Operations at Cambridge Biomedical and joined BioAgilytix’s leadership team when the company was acquired in November 2019. She has also held senior roles with Quintiles and Immucor. Commenting on her new appointment, Robbie, said: “I could not be more enthusiastic to step into this important role at BioAgilytix, as my predecessor leaves an incredible legacy of high-performing teams and growth. This is an exciting time for me but also for BioAgilytix as we chart our course forward.”   Robbie will continue to emphasize the importance of a strong science foundation and leverage the global laboratory’s innovation skills while keeping focused on an exceptional customer experience. “Patient outcomes are always our first priority as we collaborate with our sponsors to deliver accurate and reliable data for all of the studies that we support,” she shared. Euan Menzies, CEO of BioAgilytix, added: “I am delighted to welcome such a high-caliber appointment to our executive team. The skills that Linda brings to the table will be invaluable as we continue to drive forward our strategy and move towards our next phase of growth.”   “Since joining BioAgilytix in mid-June, I have been consistently impressed with Linda’s knowledge, expertise, and passion for delivering exceptional results. She has built a cohesive, high-performing team in Boston, and I am confident she will have a similar positive impact across the broader business.”

BioAgilytix Labs Frequently Asked Questions (FAQ)

  • When was BioAgilytix Labs founded?

    BioAgilytix Labs was founded in 2008.

  • Where is BioAgilytix Labs's headquarters?

    BioAgilytix Labs's headquarters is located at 2300 Englert Drive, Durham.

  • What is BioAgilytix Labs's latest funding round?

    BioAgilytix Labs's latest funding round is Acq - Fin - II.

  • How much did BioAgilytix Labs raise?

    BioAgilytix Labs raised a total of $8.98M.

  • Who are the investors of BioAgilytix Labs?

    Investors of BioAgilytix Labs include Cinven, Cobepa and Riverside Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.